Molecular Therapy - Table of Contents alert Volume 24 Issue 12

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 24, Issue 12 (December 2016) In this issue Editorial In This Issue Research Highlights Commentary Review Original Articles Corrigendum Also new AOP Advertisement In January 2017 Cell Press will take over publishing the Molecular Therapy family of journals. To keep receiving e-alerts for these titles, please visit http://www.cell.com/molecular-therapy-family/home Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement In January 2017 Cell Press will take over publishing the Molecular Therapy family of journals. To keep receiving e-alerts for these titles, please visit http://www.cell.com/molecular-therapy-family/home     Editorial Top Gene Therapy for Epidermolysis Bullosa: Sticky Business Alexander Nyström and Leena Bruckner-Tuderman Mol Ther 2016 24: 2035-2036; 10.1038/mt.2016.199 Full Text In This Issue Top In This Issue Mol Ther 2016 24: 2037; 10.1038/mt.2016.200 Full Text Research Highlights Top Research Highlights Mol Ther 2016 24: 2038; 10.1038/mt.2016.201 Full Text Commentary Top One Size Fits All?: Ethical Considerations for Examining Efficacy in First-in-Human Pluripotent Stem Cell Studies Michelle GJL Habets, Johannes JM van Delden, Sophie L Niemansburg, Harold L Atkins and Annelien L Bredenoord Mol Ther 2016 24: 2039-2042; 10.1038/mt.2016.202 Full Text Review Top The Mucus Barrier to Inhaled Gene Therapy Gregg A Duncan, James Jung, Justin Hanes and Jung Soo Suk Mol Ther 2016 24: 2043-2053; advance online publication, September 20, 2016; 10.1038/mt.2016.182 Abstract | Full Text Original Articles Top Low-dose Gene Therapy Reduces the Frequency of Enzyme Replacement Therapy in a Mouse Model of Lysosomal Storage DiseaseMTOPEN Marialuisa Alliegro, Rita Ferla, Edoardo Nusco, Chiara De Leonibus, Carmine Settembre and Alberto Auricchio Mol Ther 2016 24: 2054-2063; advance online publication, September 23, 2016; 10.1038/mt.2016.181 Abstract | Full Text Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer Ben Yue, Donglan Cai, Chenchen Liu, Changyi Fang and Dongwang Yan Mol Ther 2016 24: 2064-2077; advance online publication, September 16, 2016; 10.1038/mt.2016.180 Abstract | Full Text Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody–drug Conjugate Shan Yu, Aaron D Pearson, Reyna KV Lim, David T Rodgers, Sijia Li, Holly B Parker, Meredith Weglarz, Eric N Hampton, Michael J Bollong, Jiayin Shen, Claudio Zambaldo, Danling Wang, Ashley K Woods, Timothy M Wright, Peter G Schultz, Stephanie A Kazane, Travis S Young and Matthew S Tremblay Mol Ther 2016 24: 2078-2089; advance online publication, October 12, 2016; 10.1038/mt.2016.175 Abstract | Full Text Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100 nm Particles Yu Sakurai, Tomoya Hada, Shoshiro Yamamoto, Akari Kato, Wataru Mizumura and Hideyoshi Harashima Mol Ther 2016 24: 2090-2099; advance online publication, September 16, 2016; 10.1038/mt.2016.178 Abstract | Full Text The Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA Haitang Wang, Yuen Yi C Tam, Sam Chen, Josh Zaifman, Roy van der Meel, Marco A Ciufolini and Pieter R Cullis Mol Ther 2016 24: 2100-2108; advance online publication, September 16, 2016; 10.1038/mt.2016.179 Abstract | Full Text Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model Lianwen Zhang, Michael B Steele, Nathan Jenks, Jacquelyn Grell, Marshall Behrens, Rebecca Nace, Shruthi Naik, Mark J Federspiel, Stephen J Russell and Kah-Whye Peng Mol Ther 2016 24: 2109-2117; advance online publication, September 26, 2016; 10.1038/mt.2016.167 Abstract | Full Text Intracellular Delivery of Anti-pPKCθ (Thr538) via Protein Transduction Domain Mimics for Immunomodulation E Ilker Ozay, Gabriela Gonzalez-Perez, Joe A Torres, Jyothi Vijayaraghavan, Rebecca Lawlor, Heather L Sherman, Daniel T Garrigan, Jr, Amy S Burnside, Barbara A Osborne, Gregory N Tew and Lisa M Minter Mol Ther 2016 24: 2118-2130; advance online publication, September 16, 2016; 10.1038/mt.2016.177 Abstract | Full Text Corrigendum Top Corrigendum to “Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo” Mol Ther 2016 24: 2131-2132; 10.1038/mt.2016.197 Full Text Corrigendum to “A Self-restricted CRISPR System to Reduce Off-target Effects” Mol Ther 2016 24: 2132; 10.1038/mt.2016.198 Full Text Advertisement In January 2017 Cell Press will take over publishing the Molecular Therapy family of journals. To keep receiving e-alerts for these titles, please visit http://www.cell.com/molecular-therapy-family/home Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.